Parsonex Advisory Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-32,131
Closed -$1.37M – 55
2026
Q2
$1.37M Sell
32,131
-361
-1% -$19.6K 1.19% 25
2026
Q1
$2.04M Buy
32,492
+5,887
+22% +$471K 1.99% 25
2025
Q4
$2.54M Buy
26,605
+349
+1% +$34.2K 1.62% 21
2025
Q3
$2.56M Buy
26,256
+6,012
+30% +$623K 1.74% 21
2025
Q2
$2.17M Buy
+20,244
New +$2.05M 1.81% 20

Other funds holding BSX

Parsonex Advisory Services's BSX Position: Q3 2026 in Review

Parsonex Advisory Services sold out of Boston Scientific (BSX) in Q3 2026, closing a stake of 32,131 shares — an estimated $1.37M sold.

Parsonex Advisory Services first reported a position in BSX in Q2 2025 and held it in 5 quarters. The position peaked at $2.56M in Q3 2025. 1,512 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Parsonex Advisory Services reported no remaining Boston Scientific position as of Q3 2026 after selling out during the quarter.
  • Parsonex Advisory Services sold 32,131 Boston Scientific shares in Q3 2026, an estimated $1.37M.
  • Parsonex Advisory Services first reported a position in Boston Scientific in Q2 2025 and held it in 5 quarters.
  • Parsonex Advisory Services's Boston Scientific position peaked at $2.56M in Q3 2025.
  • 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Parsonex Advisory Services's 13F filing for Q3 2026, filed 13 Nov 2026.